Josepmaria Argemi

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 120 publications

Decoding Primary Refractoriness to Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma: The Myeloid Frontier.

Decoding Primary Refractoriness to Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma: The Myeloid Frontier.

Journal: Journal of hepatology

Published: August 04, 2026

Invasive fungal infections after liver transplantation: Risk factors and impact on mortality in a retrospective single-center cohort with propensity score matching.

Invasive fungal infections after liver transplantation: Risk factors and impact on mortality in a retrospective single-center cohort with propensity score matching.

Journal: Medicina clinica

Published: March 31, 2026

Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary strictures.

Ultra-low-pass whole-genome sequencing of bile cfDNA in patients with biliary strictures.

Journal: eGastroenterology

Published: March 25, 2026

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy.

Journal: Oncoimmunology

Published: March 19, 2026

Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients With Severe Alcohol-Associated Hepatitis.

Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients With Severe Alcohol-Associated Hepatitis.

Journal: Clinical and translational gastroenterology

Published: March 13, 2026

Calpain-4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Experimental Alcohol-Related Liver Disease.

Calpain-4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Experimental Alcohol-Related Liver Disease.

Journal: Alcohol, clinical & experimental research

Published: February 17, 2026

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Journal: Molecular therapy. Oncology

Published: January 20, 2026

Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis.

Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis.

Journal: International journal of molecular sciences

Published: December 24, 2025

Alpha diversity analysis of hepatic transcriptome reveals novel pathways in alcohol-related hepatitis.

Alpha diversity analysis of hepatic transcriptome reveals novel pathways in alcohol-related hepatitis.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Calpain-4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Alcohol-Related Liver Disease.

Calpain-4 Knockdown Modulates Cholesterol Metabolism and LXRα Nuclear Localization in Alcohol-Related Liver Disease.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021).

Trends in incidence, prevalence, and survival of primary liver cancer in the United Kingdom (2000-2021).

Journal: European journal of public health

Published: November 10, 2025

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 27, 2025

Showing 1-12 of 120

Last Updated: 09/26/2026